Discussion
The final results of a now-completed global clinical trial have confirmed that the approved infusion therapy Adzynma (ADAMTS13 recombinant-krhn) prevents acute disease episodes in people…
Thrombotic thrombocytopenic purpura is a rare, life-threatening blood disorder marked by dangerous clotting and low platelet counts. Prompt diagnosis and treatment are critical, and with proper care, most people recover and avoid serious complications.
While there’s no cure for immune thrombocytopenia, a range of treatments — from steroids to platelet-boosting therapies — can help manage symptoms. Choosing the right plan depends on platelet levels, bleeding risk, and individual health considerations.
Discussion
THROMBOTIC THROMBOCYTOPENIC PURPURA
NewsThe final results of a now-completed global clinical trial have confirmed that the approved infusion therapy Adzynma (ADAMTS13 recombinant-krhn) prevents acute disease episodes in people…
Discussion
THROMBOTIC THROMBOCYTOPENIC PURPURA
NewsThe results of a full blood count test — called a CBC, or complete blood count, by clinicians — may help distinguish people with…
Don't have an account?
|
Already have an account?
Create your account by filling in the information below:
By creating an account, you are agreeing to the Privacy Policy and Terms of Service.